Redhill Biopharma Ltd. ADR [NASDAQ: RDHL] stock went on a downward path that fall over -3.04% on N/A, amounting to a one-week price decrease of less than -23.33%.
Over the last 12 months, RDHL stock dropped by -79.52%. The one-year Redhill Biopharma Ltd. ADR stock forecast points to a potential upside of 99.79. The average equity rating for RDHL stock is currently 1.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $2.63 million, with 1.27 million shares outstanding and 1.27 million shares in the current float. Compared to the average trading volume of 94.19K shares, RDHL stock reached a trading volume of 6252259 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Redhill Biopharma Ltd. ADR [RDHL]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for RDHL shares is $1000.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on RDHL stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Cantor Fitzgerald have made an estimate for Redhill Biopharma Ltd. ADR shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on August 31, 2021. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price to Buy. The new note on the price target was released on May 18, 2021, representing the official price target for Redhill Biopharma Ltd. ADR stock.
RDHL Stock Performance Analysis:
Redhill Biopharma Ltd. ADR [RDHL] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -23.33. With this latest performance, RDHL shares dropped by -27.62% in over the last four-week period, additionally sinking by -74.06% over the last 6 months – not to mention a drop of -79.52% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for RDHL stock in for the last two-week period is set at 34.25, with the RSI for the last a single of trading hit 34.70, and the three-weeks RSI is set at 33.42 for Redhill Biopharma Ltd. ADR [RDHL]. The present Moving Average for the last 50 days of trading for this stock 3.46, while it was recorded at 2.33 for the last single week of trading, and 7.13 for the last 200 days.
Redhill Biopharma Ltd. ADR [RDHL] Institutonal Ownership Details
There are presently around $4.83%, or 4.83%% of RDHL stock, in the hands of institutional investors.
